Skip to main content
SpringerLink
Log in

Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): Biochemical Features and Therapeutic Approaches

  • Original Paper
  • Published:
Bioscience Reports

Abstract

Over the last 15 years, important research has expanded our knowledge of the clinical, molecular genetic, and biochemical features of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). The characterization of mitochondrial involvement in this disorder and the seminal determination of its genetic cause, have opened new possibilities for more detailed and deeper studies on the pathomechanisms in this progressive and fatal disease. It has been established that MNGIE is caused by mutations in the gene encoding thymidine phosphorylase (TP), which lead to absolute or nearly complete loss of its catalytic activity, producing systemic accumulations of its substrates, thymidine (dThd) and deoxyuridine (dUrd). Findings obtained from in vitro and in vivo studies indicate that the biochemical imbalances specifically impair mitochondrial DNA (mtDNA) replication, repair, or both leading to mitochondrial dysfunction. We have proposed that therapy for MNGIE should be aimed at reducing the concentrations of these toxic nucleosides to normal or nearly normal levels. The first treatment, allogeneic stem-cell transplantation (alloSCT) reported in 2006, produced a nearly full biochemical correction of the dThd and dUrd imbalances in blood. Clinical follow-up of this and other patients receiving alloSCT is necessary to determine whether this and other therapies based on a permanent restoration of TP will be effective treatment for MNGIE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296:2410–2413

    Article  PubMed  CAS  Google Scholar 

  • Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457–465

    Article  PubMed  CAS  Google Scholar 

  • Asai K, Nakanishi K, Isobe I, Eksioglu YZ, Hirano A, Hama K, Miyamoto T, Kato T (1992) Neurotrophic action of gliostatin on cortical neurons. Identity of gliostatin and platelet-derived endothelial cell growth factor. J Biol Chem 267:20311–20316

    PubMed  CAS  Google Scholar 

  • Bardosi A, Creutzfeldt W, DiMauro S, Felgenhauer K, Friede RL, Goebel HH, Kohlschutter A, Mayer G, Rahlf G, Servidei S et al (1987) Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (Berl) 74:248–258

    Article  CAS  Google Scholar 

  • Bedlack RS, Vu T, Hammans S, Sparr SA, Myers B, Morgenlander J, Hirano M (2004) MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 29:364–368

    Article  PubMed  Google Scholar 

  • Blazquez A, Martin MA, Lara MC, Marti R, Campos Y, Cabello A, Garesse R, Bautista J, Andreu AL, Arenas J (2005) Increased muscle nucleoside levels associated with a novel frameshift mutation in the thymidine phosphorylase gene in a Spanish patient with MNGIE. Neuromuscul Disord 15:775–778

    Article  PubMed  CAS  Google Scholar 

  • Bodycote J, Wolff S (1986) Metabolic breakdown of [3H]thymidine and the inability to measure human lymphocyte proliferation by incorporation of radioactivity. Proc Natl Acad Sci U S A 83:4749–4753

    Article  PubMed  CAS  Google Scholar 

  • Brown NS, Bicknell R (1998) Thymidine phosphorylase, 2-deoxy-d-ribose and angiogenesis. Biochem J 334(Pt 1):1–8

    PubMed  CAS  Google Scholar 

  • Carod-Artal FJ, Herrero MD, Lara MC, Lopez-Gallardo E, Ruiz-Pesini E, Marti R, Montoya J (2007). Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation. Eur J Neurol 14:581–585

    Article  PubMed  CAS  Google Scholar 

  • Cass CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, Jennings LL, Mackey JR, Ng AM, Ritzel MW, Vickers MF, Yao SY (1999) Nucleoside transporters of mammalian cells. Pharm Biotechnol 12:313–352

    Article  PubMed  CAS  Google Scholar 

  • Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669–672

    Article  PubMed  CAS  Google Scholar 

  • Desgranges C, Razaka G, Rabaud M, Bricaud H (1981) Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase. Biochim Biophys Acta 654:211–218

    PubMed  CAS  Google Scholar 

  • Eccleston PA, Funa K, Heldin CH (1995) Neurons of the peripheral nervous system express thymidine phosphorylase. Neurosci Lett 192:137–141

    Article  PubMed  CAS  Google Scholar 

  • el Kouni MH, el Kouni MM, Naguib FN (1993) Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines. Cancer Res 53:3687–3693

    PubMed  Google Scholar 

  • Elpeleg O, Miller C, Hershkovitz E, Bitner-Glindzicz M, Bondi-Rubinstein G, Rahman S, Pagnamenta A, Eshhar S, Saada A (2005) Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76:1081–1086

    Article  PubMed  CAS  Google Scholar 

  • Fairbanks LD, Marinaki AM, Carrey EA, Hammans SR, Duley JA (2002) Deoxyuridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE). J Inherit Metab Dis 25:603–604

    Article  PubMed  CAS  Google Scholar 

  • Ferraro P, Pontarin G, Crocco L, Fabris S, Reichard P, Bianchi V (2005) Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 280:24472–24480

    Article  PubMed  CAS  Google Scholar 

  • Focher F, Spadari S (2001) Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy. Curr Cancer Drug Targets 1:141–153

    Article  PubMed  CAS  Google Scholar 

  • Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL (1995) Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 176:183–190

    Article  PubMed  CAS  Google Scholar 

  • Gamez J, Ferreiro C, Accarino ML, Guarner L, Tadesse S, Marti RA, Andreu AL, Raguer N, Cervera C, Hirano M (2002) Phenotypic variability in a Spanish family with MNGIE. Neurology 59:455–457

    Article  PubMed  CAS  Google Scholar 

  • Gamez J, Lara MC, Mearin F, Oliveras-Ley C, Raguer N, Olive M, Leist AT, Perello A, Perona M, Cervera C, Andreu AL, Marti R, Hirano M (2005) A novel thymidine phosphorylase mutation in a Spanish MNGIE patient. J Neurol Sci 228:35–39

    Article  PubMed  CAS  Google Scholar 

  • Giordano C, Sebastiani M, Plazzi G, Travaglini C, Sale P, Pinti M, Tancredi A, Liguori R, Montagna P, Bellan M, Valentino ML, Cossarizza A, Hirano M, d’Amati G, Carelli V (2006) Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. Gastroenterology 130:893–901

    Article  PubMed  CAS  Google Scholar 

  • Griffiths L., Stratford IJ (1997) Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy. Br J Cancer 76:689–693

    PubMed  CAS  Google Scholar 

  • Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419

    Google Scholar 

  • Hagiwara K, Stenman G, Honda H, Sahlin P, Andersson A, Miyazono K, Heldin CH, Ishikawa F, Takaku F (1991) Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol Cell Biol 11:2125–2132

    PubMed  CAS  Google Scholar 

  • Hirano M, Garcia-de-Yebenes J, Jones AC, Nishino I, DiMauro S, Carlo JR, Bender AN, Hahn AF, Salberg LM, Weeks DE, Nygaard TG (1998) Mitochondrial neurogastrointestinal encephalomyopathy syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet 63:526–533

    Article  PubMed  CAS  Google Scholar 

  • Hirano M, Marti R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH Jr, Savage DG (2006) Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458–1460

    Article  PubMed  CAS  Google Scholar 

  • Hirano M, Marti R, Ferreiro-Barros C, Vila MR, Tadesse S, Nishigaki Y, Nishino I, Vu TH (2001) Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin Cell Dev Biol 12:417–427

    Article  PubMed  CAS  Google Scholar 

  • Hirano M, Nishigaki Y, Marti R (2004) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 10:8–17

    Article  PubMed  Google Scholar 

  • Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, Hays AP, Lovelace RE, Butler I, Bertorini TE et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721–727

    PubMed  CAS  Google Scholar 

  • Kaukonen J, Juselius JK, Tiranti V, Kyttala A, Zeviani M, Comi GP, Keranen S, Peltonen L, Suomalainen A (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289:782–785

    Article  PubMed  CAS  Google Scholar 

  • Kocaefe YC, Erdem S, Ozguc M, Tan E (2003) Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patients. Eur J Hum Genet 11:102–104

    Article  PubMed  CAS  Google Scholar 

  • Kono A, Hara Y, Sugata S, Matsushima Y, Ueda T (1984) Substrate specificity of a thymidine phosphorylase in human liver tumor. Chem Pharm Bull (Tokyo) 32:1919–1921

    CAS  Google Scholar 

  • Kumagai Y, Sugiura Y, Sugeno H, Takebayashi Y, Takenoshita S, Yamamoto T (2006) Thymidine phosphorylase gene mutation is not a primary cause of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Intern Med 45:443–446

    Article  PubMed  Google Scholar 

  • Lai Y, Tse CM, Unadkat JD (2004) Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J Biol Chem 279:4490–4497

    Article  PubMed  CAS  Google Scholar 

  • Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL, Valentino ML, Anikster Y, Hirano M, Marti R (2006) Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 67:1461–1463

    Article  PubMed  CAS  Google Scholar 

  • Lee EW, Lai Y, Zhang H, Unadkat JD (2006) Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine. J Biol Chem 281:16700–16706

    Article  PubMed  CAS  Google Scholar 

  • Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, Anbinder Y, Berkowitz D, Hartman C, Barak M, Eriksson S, Cohen N (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337–341

    Article  PubMed  CAS  Google Scholar 

  • Marti R, Nishigaki Y, Hirano M (2003) Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Commun 303:14–18

    Article  PubMed  CAS  Google Scholar 

  • Marti R, Spinazzola A, Tadesse S, Nishino I, Nishigaki Y, Hirano M (2004) Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 50:120–124

    Article  PubMed  CAS  Google Scholar 

  • Marti R, Verschuuren JJ, Buchman A, Hirano I, Tadesse S, van Kuilenburg AB, van Gennip AH, Poorthuis BJ, Hirano M (2005) Late-onset MNGIE due to partial loss of thymidine phosphorylase activity. Ann Neurol 58:649–652

    Article  PubMed  CAS  Google Scholar 

  • Martin MA, Blaz quez A, Marti R, Bautista J, Lara MC, Cabello A, Campos Y, Belda O, Andreu AL, Arenas J (2004) Lack of gastrointestinal symptoms in a 60-year-old patient with MNGIE. Neurology 63:1536–1537

    PubMed  CAS  Google Scholar 

  • Matsukawa K, Moriyama A, Kawai Y, Asai K, Kato T (1996) Tissue distribution of human gliostatin/platelet-derived endothelial cell growth factor (PD-ECGF) and its drug-induced expression. Biochim Biophys Acta 1314:71–82

    Article  PubMed  Google Scholar 

  • Millar WS, Lignelli A, Hirano M (2004) MRI of five patients with mitochondrial neurogastrointestinal encephalomyopathy. AJR Am J Roentgenol 182:1537–1541

    PubMed  Google Scholar 

  • Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH (1987) Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262:4098–4103

    PubMed  CAS  Google Scholar 

  • Miyazono K, Takaku F (1991) Platelet-derived endothelial cell growth factor: structure and function. Jpn Circ J 55:1022–1026

    PubMed  CAS  Google Scholar 

  • Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A 92:998–1002

    Article  PubMed  CAS  Google Scholar 

  • Needham M, Duley J, Hammond S, Herkes GK, Hirano M, Sue CM (2007) Mitochondrial disease mimicking Charcot-Marie Tooth disease. J Neurol Neurosurg Psychiatry 78:99–100

    Article  PubMed  CAS  Google Scholar 

  • Nishigaki Y, Marti R, Copeland WC, Hirano M (2003) Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111:1913–1921

    Article  PubMed  CAS  Google Scholar 

  • Nishigaki Y, Marti R, Hirano M (2004) ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy. Hum Mol Genet 13:91–101

    Article  PubMed  CAS  Google Scholar 

  • Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689–692

    Article  PubMed  CAS  Google Scholar 

  • Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD, Connolly AM, Verloes A, Guimaraes J, Maillard I, Hamano H, Donati MA, Semrad CE, Russell JA, Andreu AL, Hadjigeorgiou GM, Vu TH, Tadesse S, Nygaard TG, Nonaka I, Hirano I, Bonilla E, Rowland LP, DiMauro S, Hirano M (2000) Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 47:792–800

    Article  PubMed  CAS  Google Scholar 

  • Pontarin G, Ferraro P, Valentino ML, Hirano M, Reichard P, Bianchi V (2006) Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy. J Biol Chem 281:22720–22728

    Article  PubMed  CAS  Google Scholar 

  • Pontarin G, Gallinaro L, Ferraro P, Reichard P, Bianchi V (2003) Origins of mitochondrial thymidine triphosphate: dynamic relations to cytosolic pools. Proc Natl Acad Sci U S A 100:12159–12164

    Article  PubMed  CAS  Google Scholar 

  • Rampazzo C, Ferraro P, Pontarin G, Fabris S, Reichard P, Bianchi V (2004) Mitochondrial deoxyribonucleotides, pool sizes, synthesis, and regulation. J Biol Chem 279:17019–17026

    Article  PubMed  CAS  Google Scholar 

  • Rowland LP, Blake DM, Hirano M, Di Mauro S, Schon EA, Hays AP, Devivo DC (1991) Clinical syndromes associated with ragged red fibers. Rev Neurol (Paris) 147:467–473

    CAS  Google Scholar 

  • Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29:342–344

    Article  PubMed  CAS  Google Scholar 

  • Schupbach WM, Vadday KM, Schaller A, Brekenfeld C, Kappeler L, Benoist JF, Xuan-Huong CN, Burgunder JM, Seibold F, Gallati S, Mattle HP (2007) Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: Clinical, genetic and neuroradiological features. J Neurol 254:146–153

    Google Scholar 

  • Slama A, Lacroix C, Plante-Bordeneuve V, Lombes A, Conti M, Reimund JM, Auxenfants E, Crenn P, Laforet P, Joannard A, Seguy D, Pillant H, Joly P, Haut S, Messing B, Said G, Legrand A, Guiochon-Mantel A (2005) Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome. Mol Genet Metab 84:326–331

    Article  PubMed  CAS  Google Scholar 

  • Song S, Wheeler LJ, Mathews CK (2003) Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J Biol Chem 278:43893–43896

    Article  PubMed  CAS  Google Scholar 

  • Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, Pela I, Zammarchi E, Donati MA, Oliver JA, Hirano M (2002) Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277:4128–4133

    Article  PubMed  CAS  Google Scholar 

  • Szigeti K, Wong LJ, Perng CL, Saifi GM, Eldin K, Adesina AM, Cass DL, Hirano M, Lupski JR, Scaglia F (2004) MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation. J Med Genet 41:125–129

    Article  PubMed  CAS  Google Scholar 

  • Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH (1992) Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 184:1311–1316

    Article  PubMed  CAS  Google Scholar 

  • Waltenberger J, Usuki K, Fellstrom B, Funa K, Heldin CH (1992) Platelet-derived endothelial cell growth factor. Pharmacokinetics, organ distribution and degradation after intravenous administration in rats. FEBS Lett 313:129–132

    Article  PubMed  CAS  Google Scholar 

  • Wraith JE (2006) Limitations of enzyme replacement therapy: current and future. J Inherit Metab Dis 29:442–447

    Article  PubMed  CAS  Google Scholar 

  • Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S (1990) Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1034:107–113

    PubMed  CAS  Google Scholar 

  • Zaharko DS, Bolten BJ, Chiuten D, Wiernik PH (1979) Pharmacokinetic studies during phase I trials of high-dose thymidine infusions. Cancer Res 39:4777–4781

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Spanish Fondo de Investigación Sanitaria (FIS 03/0343; FIS 04/0242 and FIS 06/0735), a grant from the United Mitochondrial Disease Foundation (UMDF 04–42), a grant from the Muscular Dystrophy Association USA, NIH grant NS11766, and the Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF).

Author information

Authors and Affiliations

  1. Centre d’Investigacions en Bioquímica i Biologia Molecular, Institut de Recerca Hospital Universitari Vall d’Hebron and Centre for Biomedical Research on Rare Diseases (CIBERER), ISCIII, P. Vall d’Hebron 119-129, 08035, Barcelona, Spain

    M. C. Lara, J. Torres-Torronteras & R. Martí

  2. Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA

    M. L. Valentino & M. Hirano

Authors
  1. M. C. Lara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. L. Valentino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Torres-Torronteras
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Hirano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Martí
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Martí.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lara, M.C., Valentino, M.L., Torres-Torronteras, J. et al. Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): Biochemical Features and Therapeutic Approaches. Biosci Rep 27, 151–163 (2007). https://doi.org/10.1007/s10540-007-9043-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10540-007-9043-2

Keywords

Search

Navigation